Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas

NCT07032285 is registered in ClinicalTrials.gov with Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas as lead sponsor.

NCT NCT07032285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07032285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Lead sponsor
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Phase
Phase 2
Overall status
Recruiting
Start date
January 15, 2025
Completion date
July 30, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma (sts)